Genomic Health (GHDX)
Add to Watchlists Create an AlertGenomic Health Cash and Equivalents
Genomic Health Cash and Equivalents Chart
View Cash and Equivalents for GHDX.
Start Your YCharts Pro Platinum Membership.
Genomic Health Historical Cash and Equivalents Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | Go Pro |
| Dec. 31, 2012 | Go Pro |
| Sept. 30, 2012 | Go Pro |
| June 30, 2012 | Go Pro |
| March 31, 2012 | Go Pro |
| Dec. 31, 2011 | Go Pro |
| Sept. 30, 2011 | Go Pro |
| June 30, 2011 | Go Pro |
| March 31, 2011 | Go Pro |
| Dec. 31, 2010 | Go Pro |
| Sept. 30, 2010 | Go Pro |
| June 30, 2010 | Go Pro |
| March 31, 2010 | Go Pro |
| Dec. 31, 2009 | Go Pro |
| Sept. 30, 2009 | Go Pro |
| June 30, 2009 | Go Pro |
| March 31, 2009 | Go Pro |
| Dec. 31, 2008 | Go Pro |
| Sept. 30, 2008 | Go Pro |
| June 30, 2008 | Go Pro |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
About Cash and Equivalents
Cash and equivalents is cash or cash equivalents that a company possesses at any given time. Examples of cash equivalents are: money market accounts, treasury bills, and short term government bonds. Cash and cash equivalents are a business' most liquid assets. Cash on hand results from a positive cash flow statement.
Investors look at cash on hand as a reflection of a company's solvency and liquidity.
Learn More
View Cash and Equivalents for GHDX.
Start Your YCharts Pro Platinum Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $199/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Platinum Member? Sign in here.
GHDX Cash and Equivalents Benchmarks
| Companies | |
|---|---|
| Myriad Genetics | Go Pro |
| Trius Therapeutics | Go Pro |
| Abaxis | Go Pro |
GHDX Cash and Equivalents Rankings
| Overall |
54th percentile 3443 of 7600 |
| Sector |
45th percentile 355 of 653 in Healthcare |
| Industry |
44th percentile 34 of 61 in Diagnostics & Research |
GHDX Cash and Equivalents Range, Past 5 Years
| Minimum | Go Pro | Mar 2010 |
| Maximum | Go Pro | Sep 2012 |
| Average | Go Pro |